People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Other Energy, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nexamp, Inc. | — | Other Energy | Series D+ | $600.4M | $3.1B | 2021 |
| Reprise Biomedical, Inc. | — | Biotechnology | Series B | $47.1M | $29.7M | 2019 |
| Miromatrix Medical Inc. | — | Biotechnology | Series B | $44.8M | $623.9M | 2011 |
| Luminary Therapeutics, Inc. | — | Biotechnology | Series A | $14.5M | $4.0M | 2022 |
Jeff Ross at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeff Ross on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ronald Eibensteiner | 2 | 3 |
| John Murphy | 1 | 17 |
| Robert Cohen | 1 | 11 |
| David Martirano | 1 | 11 |
| Paul Buckman | 1 | 10 |
| Christopher Clark | 1 | 7 |
| Zaid Ashai | 1 | 6 |
| Timothy J. Flynn | 1 | 5 |
| Jeffrey Ross | 1 | 5 |
| Timothy J. Pawlenty | 1 | 4 |
| Erwin Kelen | 1 | 4 |
| Jeff Liter | 1 | 3 |
| John Hurley | 1 | 3 |
| John Wells | 1 | 2 |
| David J. Martirano | 1 | 2 |
| David Largaespada | 1 | 2 |
| Joseph J. Alexander | 1 | 2 |
| James S. Eisenstein | 1 | 2 |
| Harald C. Ott | 1 | 2 |
| Branden Moriarity | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.